322 related articles for article (PubMed ID: 17294242)
1. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
Jinawath A; Akiyama Y; Sripa B; Yuasa Y
J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway.
Lu JT; Zhao WD; He W; Wei W
Acta Pharmacol Sin; 2012 May; 33(5):691-700. PubMed ID: 22543708
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
[TBL] [Abstract][Full Text] [Related]
4. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
5. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip-Schneider MT; Schmidt CM
Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
[TBL] [Abstract][Full Text] [Related]
6. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.
Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S
Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031
[TBL] [Abstract][Full Text] [Related]
7. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.
Fingas CD; Bronk SF; Werneburg NW; Mott JL; Guicciardi ME; Cazanave SC; Mertens JC; Sirica AE; Gores GJ
Hepatology; 2011 Dec; 54(6):2076-88. PubMed ID: 22038837
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
[TBL] [Abstract][Full Text] [Related]
9. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.
Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A
Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164
[TBL] [Abstract][Full Text] [Related]
10. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
[TBL] [Abstract][Full Text] [Related]
11. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog pathway as a potential treatment target in human cholangiocarcinoma.
Riedlinger D; Bahra M; Boas-Knoop S; Lippert S; Bradtmöller M; Guse K; Seehofer D; Bova R; Sauer IM; Neuhaus P; Koch A; Kamphues C
J Hepatobiliary Pancreat Sci; 2014 Aug; 21(8):607-15. PubMed ID: 24733827
[TBL] [Abstract][Full Text] [Related]
13. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
Matsumoto K; Okano J; Nagahara T; Murawaki Y
Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
[TBL] [Abstract][Full Text] [Related]
15. ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins.
Bai L; Mao R; Wang J; Ding L; Jiang S; Gao C; Kang H; Chen X; Sun X; Xu J
Med Oncol; 2015 Mar; 32(3):57. PubMed ID: 25647783
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
[TBL] [Abstract][Full Text] [Related]
17. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment.
Dokduang H; Juntana S; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3519-28. PubMed ID: 23812726
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
[TBL] [Abstract][Full Text] [Related]
20. Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
Fingas CD; Mertens JC; Razumilava N; Sydor S; Bronk SF; Christensen JD; Rizvi SH; Canbay A; Treckmann JW; Paul A; Sirica AE; Gores GJ
Hepatology; 2013 Oct; 58(4):1362-74. PubMed ID: 23703673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]